Dima Sabbah

Dima Sabbah

Al-Zaytoonah University of Jordan

H-index: 19

Asia-Jordan

About Dima Sabbah

Dima Sabbah, With an exceptional h-index of 19 and a recent h-index of 15 (since 2020), a distinguished researcher at Al-Zaytoonah University of Jordan, specializes in the field of Computational Chemistry, Medicinal Chemistry, Drug Design, Drug Discovery, Organic Chemistry.

His recent articles reflect a diverse array of research interests and contributions to the field:

Targeting the PI3K/AKT signaling pathway in anticancer research: a recent update on inhibitor design and clinical trials (2020-2023)

Targeting the EGFR/RAS/RAF signaling pathway in anticancer research: a recent update on inhibitor design and clinical trials (2020–2023)

Identifying a causal link between prolactin signaling pathways and COVID-19 vaccine-induced menstrual changes

A cross-sectional study confirms temporary post-COVID-19 vaccine menstrual irregularity and the associated physiological changes among vaccinated women in Jordan

Progress in the Design and Development of Phosphoinositide-3-Kinase (PI3Kα) Inhibitors

Synthesis, Molecular Modeling and Biological Evaluation of Novel Trifluoromethyl Benzamides as Promising CETP Inhibitors.

Trifluoromethylated aryl sulfonamides as novel CETP inhibitors: Synthesis, induced fit docking, pharmacophore mapping and subsequent in vitro validation

A Critical Assessment of COVID-19 Genomic Vaccines

Dima Sabbah Information

University

Position

College of Pharmacy

Citations(all)

1334

Citations(since 2020)

1077

Cited By

484

hIndex(all)

19

hIndex(since 2020)

15

i10Index(all)

35

i10Index(since 2020)

33

Email

University Profile Page

Al-Zaytoonah University of Jordan

Google Scholar

View Google Scholar Profile

Dima Sabbah Skills & Research Interests

Computational Chemistry

Medicinal Chemistry

Drug Design

Drug Discovery

Organic Chemistry

Top articles of Dima Sabbah

Title

Journal

Author(s)

Publication Date

Targeting the PI3K/AKT signaling pathway in anticancer research: a recent update on inhibitor design and clinical trials (2020-2023)

Dima A Sabbah

Rima Hajjo

Sanaa K Bardaweel

Haizhen A Zhong

2024/3/3

Targeting the EGFR/RAS/RAF signaling pathway in anticancer research: a recent update on inhibitor design and clinical trials (2020–2023)

Rima Hajjo

Dima A Sabbah

Sanaa K Bardaweel

Haizhen A Zhong

2024/2/1

Identifying a causal link between prolactin signaling pathways and COVID-19 vaccine-induced menstrual changes

npj Vaccines

Rima Hajjo

Ensaf Momani

Dima A Sabbah

Nancy Baker

Alexander Tropsha

2023/9/1

A cross-sectional study confirms temporary post-COVID-19 vaccine menstrual irregularity and the associated physiological changes among vaccinated women in Jordan

Frontiers in Medicine

Ensaf Y Almomani

Rima Hajjo

Ahmad Qablan

Dima A Sabbah

Abass Al-Momany

2023

Progress in the Design and Development of Phosphoinositide-3-Kinase (PI3Kα) Inhibitors

Jordan Journal of Pharmaceutical Sciences

Dima A Sabbah

2023/7/24

Synthesis, Molecular Modeling and Biological Evaluation of Novel Trifluoromethyl Benzamides as Promising CETP Inhibitors.

Turkish Journal of Chemistry

Fulya Günay

Sevcan Balta

Yuk Yin Ng

ÖZLEM ULUCAN AÇAN

ZÜHAL TURGUT

...

2022

Trifluoromethylated aryl sulfonamides as novel CETP inhibitors: Synthesis, induced fit docking, pharmacophore mapping and subsequent in vitro validation

Medicinal Chemistry (Shariqah (United Arab Emirates))

Reema Abu Khalaf

HA Shaiah

Dima Sabbah

2023

A Critical Assessment of COVID-19 Genomic Vaccines

Dima A Sabbah

Rima Hajjo

Suhair Sunoqrot

2023/10/1

Targeting Human Proteins for Antiviral Drug Discovery and Repurposing Efforts: A Focus on Protein Kinases

Rima Hajjo

Dima A Sabbah

Osama H Abusara

Reham Kharmah

Sanaa Bardaweel

2023/2/19

Synthesis and Molecular Modeling of Novel 3, 5-Bis (trifluoromethyl) benzylamino Benzamides as Potential CETP Inhibitors

Medicinal Chemistry (Shariqah (United Arab Emirates))

Reema Abu Khalaf

Mohammad Awad

Tariq Al-Qirim

Dima Sabbah

2022

Novel derivatives of 4, 6‐Dihydroxy‐2‐quinolone‐3‐carboxamides as potential PI3Kα inhibitors

ChemistrySelect

Kamal Sweidan

Hussein Elfadel

Dima A Sabbah

Sanaa K Bardaweel

Rima Hajjo

...

2022/8/26

Design, synthesis, and biological evaluation of novel MAO-A inhibitors targeting lung cancer

Future Journal of Pharmaceutical Sciences

Iten M Fawzy

Khairia M Youssef

Nasser SM Ismail

Joachim Gullbo

Khaled AM Abouzid

2015/6/1

Unlocking the potential of the human microbiome for identifying disease diagnostic biomarkers

Rima Hajjo

Dima A Sabbah

Abdel Qader Al Bawab

2022/7/19

A review of the recent advances in Alzheimer’s disease research and the utilization of network biology approaches for prioritizing diagnostics and therapeutics

Rima Hajjo

Dima A Sabbah

Osama H Abusara

Abdel Qader Al Bawab

2022/11/28

The in vitro immunomodulatory effects of gold nanocomplex on THP-1-derived macrophages

Journal of Immunology Research

Duaa Abuarqoub

Nouf N Mahmoud

Rand Zaza

Rana Abu-Dahab

Enam A Khalil

...

2022/2/10

SYNTHESIS, CHARACTERIZATION AND BIOLOGICAL SCREENING OF NEW N-SUBSTITUTED-7-CHLORO-4-HYDROXY-2-QUINOLONE-3-CARBOXAMIDES AS PROMISING ANTICANCER AGENTS

Applied Organometallic Chemistry

Sajjad H Sumrra

Abrar U Hassan

Muhammad Imran

Muhammad Khalid

Ehsan U Mughal

...

2020/7

Cholesteryl ester transfer protein inhibitory oxoacetamido-benzamide derivatives: Glide docking, pharmacophore mapping, and synthesis

Brazilian Journal of Pharmaceutical Sciences

Reema Abu Khalaf

Areej NasrAllah

Wassan Jarrar

Dima A Sabbah

2022/11/4

Fluorinated Benzyloxalamides: Glide Docking, Pharmacophore Mapping, Synthesis and In Vitro Evaluation as Potential Cholesteryl Ester Transfer Protein Inhibitors.

Indian Journal of Pharmaceutical Sciences

R KHALAF

D Sabbah

E Al-Shalabi

B Ikhmais

W Naser

...

2022/11/1

Analyzing the systems biology effects of COVID-19 mRNA vaccines to assess their safety and putative side effects

Pathogens

Rima Hajjo

Dima A Sabbah

Alexander Tropsha

2022/6/29

Phenanthridine sulfonamide derivatives as potential DPP-IV inhibitors: design, synthesis and biological evaluation

Current Computer-aided Drug Design

Reema Abu Khalaf

Shorooq Alqazaqi

Maram Aburezeq

Dima Sabbah

Ghadeer Albadawi

...

2022

See List of Professors in Dima Sabbah University(Al-Zaytoonah University of Jordan)

Co-Authors

H-index: 46
Mohammad S. Mubarak

Mohammad S. Mubarak

University of Jordan

H-index: 26
Jian hu

Jian hu

Michigan State University

H-index: 18
Yusuf Al-Hiari

Yusuf Al-Hiari

University of Jordan

H-index: 17
Kamal Sweidan

Kamal Sweidan

University of Jordan

H-index: 12
Reema Abu Khalaf

Reema Abu Khalaf

Al-Zaytoonah University of Jordan

academic-engine